Carlos C. Alonso
Campinas, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dual molecular axis of resistance and immunoresponsiveness to BCG in pT1 non-muscle invasive bladder cancer: Insights from HER-2, SERBP1, HABP4, and IFN-γ profiling.
Journal: Tissue & cell
Published: July 22, 2025
Graphene oxide nanoscaffold functionalized with adipose-derived mesenchymal stem cells and sildenafil promotes urethral stricture repair and tissue regeneration.
Journal: Tissue & cell
Published: June 14, 2025
The Activation of the NF-κB Pathway in Human Adipose-Derived Stem Cells Alters the Deposition of Epigenetic Marks on H3K27 and Is Modulated by Fish Oil.
Journal: Life (Basel, Switzerland)
Published: October 31, 2024
Clinical and immunohistochemical effects of OncoTherad (MRB-CFI-1) nanoimmunotherapy on SERBP1, HABP4, CD44 and Ki-67 in BCG-unresponsive non-muscle invasive bladder cancer.
Journal: Tissue & cell
Published: October 18, 2024
Modulation of the tumor microenvironment in non-muscle-invasive bladder cancer by OncoTherad® (MRB-CFI-1) nanoimmunotherapy: effects on tumor-associated macrophages, tumor-infiltrating lymphocytes, and monoamine oxidases.
Journal: Medical oncology (Northwood, London, England)
Published: June 14, 2024
OncoTherad® (MRB-CFI-1) Nanoimmunotherapy: A Promising Strategy to Treat Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: Crosstalk among T-Cell CX3CR1, Immune Checkpoints, and the Toll-Like Receptor 4 Signaling Pathway.
Journal: International journal of molecular sciences
Published: November 08, 2023
Is there room for behavioral and modifiable health-related targets in the lower urinary tract symptoms' scenario.
Journal: World journal of urology
Published: October 22, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026